These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3855853)

  • 1. 7-Hydroxy-methotrexate and clinical toxicity following high-dose methotrexate therapy.
    Erttmann R; Bielack S; Landbeck G
    J Cancer Res Clin Oncol; 1985; 109(1):86-8. PubMed ID: 3855853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy.
    Erttmann R; Bielack S; Landbeck G
    Cancer Chemother Pharmacol; 1985; 15(2):101-4. PubMed ID: 3874719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of plasma methotrexate and 7-hydroxy methotrexate by UHPLC-MS/MS in patients receiving high-dose methotrexate therapy.
    Mei S; Shi X; Du Y; Cui Y; Zeng C; Ren X; Yu K; Zhao Z; Lin S
    J Pharm Biomed Anal; 2018 Sep; 158():300-306. PubMed ID: 29909319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate clearance and clinical toxicity in osteosarcoma following high-dose methotrexate therapy.
    Iqbal MP; Khursheed M; Mahboobali N
    J Pak Med Assoc; 1989 Feb; 39(2):38-42. PubMed ID: 2499702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose methotrexate for osteosarcoma: toxicity and clinical results.
    Breithaupt H; Küenzlen E
    Oncology; 1983; 40(2):85-9. PubMed ID: 6600827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic and enzyme-inhibition assays of methotrexate concentrations in serum from patients receiving high-dose therapy: tight binding of some methotrexate to a protein that could be dihydrofolate reductase.
    Iven H; Bartels H
    Cancer Treat Rep; 1985; 69(7-8):825-32. PubMed ID: 4016793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate test-dose protocol in the presence of 7-hydroxy-methotrexate.
    Lena N; Imbert AM; Favre R; Cano JP; Carcassonne Y
    Eur J Cancer Clin Oncol; 1987 May; 23(5):481-5. PubMed ID: 3477455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia.
    Borsi JD; Sagen E; Romslo I; Slørdal L; Moe PJ
    Cancer Chemother Pharmacol; 1990; 27(2):164-7. PubMed ID: 2249335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful desensitization to high-dose methotrexate after systemic anaphylaxis.
    Davis KA; Williams P; Walker JC
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):87-9. PubMed ID: 12546343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose leucovorin as sole therapy for methotrexate toxicity.
    Flombaum CD; Meyers PA
    J Clin Oncol; 1999 May; 17(5):1589-94. PubMed ID: 10334548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of methotrexate by the ligand-binding assay after "high-dose" therapy for osteosarcoma.
    Roberts D; Kidd W; Pratt CB; Peck C; Grinnel J
    Cancer; 1979 Sep; 44(3):881-90. PubMed ID: 314328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid-liquid extraction in the 96-well plate format with SRM LC/MS quantitative determination of methotrexate and its major metabolite in human plasma.
    Steinborner S; Henion J
    Anal Chem; 1999 Jul; 71(13):2340-5. PubMed ID: 10405602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model.
    Smeland E; Fuskevåg OM; Nymann K; Svendesn JS; Olsen R; Lindal S; Bremnes RM; Aarbakke J
    Cancer Chemother Pharmacol; 1996; 37(5):415-22. PubMed ID: 8599863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate and 7-hydroxymethotrexate: serum level monitoring by high-performance liquid chromatography.
    Canfell C; Sadée W
    Cancer Treat Rep; 1980 Jan; 64(1):165-9. PubMed ID: 7379052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
    Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
    Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
    Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
    Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection by high-performance liquid chromatography of methotrexate and its metabolites in tumor tissue from osteosarcoma patients treated with high-dose methotrexate/leucovorin rescue.
    Samuels LL; Feinberg A; Moccio DM; Sirotnak FM; Rosen G
    Biochem Pharmacol; 1984 Sep; 33(17):2711-4. PubMed ID: 6205660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 7-hydroxymethotrexate in human plasma by reversed phase high-performance liquid chromatography.
    Erttmann R; Bielack S; Landbeck G
    Oncology; 1986; 43(2):86-8. PubMed ID: 3456549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the 48-hour plasma level in high-dose methotrexate regimens.
    Perez C; Wang YM; Sutow WW; Herson J
    Cancer Clin Trials; 1978; 1(2):107-11. PubMed ID: 316368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.
    Saeter G; Alvegård TA; Elomaa I; Stenwig AE; Holmström T; Solheim OP
    J Clin Oncol; 1991 Oct; 9(10):1766-75. PubMed ID: 1717666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.